Debra Robinson
Senior Project Management Consultant & Advisor @Global Project Partners, Llc
Signup · Get unlimited contacts
WORK HISTORY
Senior Project Management Consultant & Advisor @Global Project Partners, Llc
San Francisco Bay, CA, US
Highlights of Client Engagements: Led the development of a cross-functional project plan spanning preclinical through Ph 2 clinical trial. Integrated resource planning and budget forecasting to ensure operational readiness and the successful, on-time initiation of the company\'s FIH clinical trial.🧭 Co-led a critical path analysis to optimize program timelines. Facilitated cross-functional discussion to incorporate an additional treatment arm in the FIH study and proactively establish drug supply strategies, preventing potential stock-outs during the Phase 1 trial. Designed and implemented a regulatory roadmap to support a successful BLA/MAA submission. Advised on regulatory filing team structure and key roles to drive efficient, well-coordinated submission activities. Built dynamic project dashboards to track program milestones and filing deliverables. Recommended and configured enterprise project management tools (Smartsheet, MS Project) to improve planning, visibility, and cross-functional coordination.
EDUCATION
University of Illinois Chicago
BS
Keller Graduate School of Management of DeVry University
MBA/MPM
ABOUT DEBRA ROBINSON
I’m a biopharma program and project management leader with 20+ years of global drug development experience across public and private life sciences companies. I bring calm, structured leadership to complex programs—aligning cross-functional teams, decisions, and execution from IND through commercial launch.My work is deeply personal. Inspired by my father’s battle with a rare form of cancer, I’m committed to advancing therapies for patients with serious illnesses—combining urgency with rigor and operational discipline.I’ve led global programs across biologics, small molecules, and cell therapies in diabetes, hematology-oncology, oncology, biosimilars, and immuno-oncology. The five commercial therapies I’ve championed collectively reached $3B in value, reflecting a consistent focus on execution and patient impact.Selected highlights:• First-in-Human Immuno-oncology Execution: Directed program planning and co-led a cross-functional team to initiate the first conditionally active bispecific T-cell engager Phase 1/2 study, supporting key decisions that contributed to Maverick Therapeutics’ acquisition by Takeda.• Commercial Launch Leadership (Defitelio®): Directed launch planning and co-led the Defitelio® Launch Team across regulatory, marketing, medical affairs, and payer strategy; ensured commercial supply readiness and supported label discussions, enabling the successful U.S. launch of the first approved treatment for veno-occlusive disease (VOD).• Global Product Strategy & Lifecycle (Nplate®): Directed Phase 3 clinical project planning and co-led the Nplate® Product Strategy Team, supporting approvals and launches in 30+ countries for immune thrombocytopenia (ITP). Led cross-functional execution of product enhancements (reconstitution kits; pediatric SKU readiness) to improve access and outcomes.I have also contributed my expertise to patient-led rare disease organizations and nonprofit boards, supporting research acceleration, education, and community-driven impact.Core strengths:• Cross-functional Program & Project Leadership• Strategic & Operational Planning (Program + Regulatory Roadmaps)• Alliance Management, Governance & Executive Communication• Budget Planning & Program Financial Reporting• Change Management & Culture BuildingIf you’re hiring for a senior project & program management leadership role, I’m open to connecting.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.